Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced a series of milestones that significantly advance the clinical adoption of blood-based Alzheimers testing. Together, these milestones reinforce the growing role of LucentAD Complete, Quanterixs...